针对风湿关节炎的个性化医疗
Seema D Sharma1, James Bluett1
1Centre for Musculoskeletal Research, Division of Musculoskeletal & Dermatological Sciences, School of Biological Sciences, University of Manchester, Manchester, UK.
Open access rheumatology : research and reviews
|May 23, 2024
概括
在类风湿性关节炎 (RA) 中预测药物反应对于个性化医学至关重要. 鉴定生物标志物将有助于将患者与最有效的抗风湿药物相匹配,改善治疗结果.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 药物基因组学 药物基因组学
背景情况:
- 类风湿性关节炎 (RA) 是一种慢性多系统性炎症性疾病.
- 目前针对RA的先进疗法缺乏普遍的有效性,导致治疗反应的平原.
- 个性化医疗需要预测标志物,以便在RA中选择最佳药物.
研究的目的:
- 审查目前对预测RA中抗风湿性药物反应的理解.
- 识别阻碍RA个性化药物的发展的障碍.
- 概述未来的研究重点,以克服这些障碍.
主要方法:
- 关于RA药物反应的预测标志物研究的文献评论.
- 分析在风湿病学中实施个性化医学的挑战.
- 综合当前的知识和未来的研究方向.
主要成果:
- 对于类风湿性关节炎,没有一种单一的先进疗法是普遍有效的.
- 药物反应的预测标志物对于个性化RA治疗至关重要.
- 显著的障碍阻碍了个性化医疗方法的开发和整合.
结论:
- 在RA中个性化医疗需要发现和应用预测生物标志物.
- 克服个性化医学的障碍需要集中研究努力.
- 未来的研究应该优先发展和验证针对性RA治疗的预测标记.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
131
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
131
Autoimmune Disorders
417
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
417


